Next-generation Sequencing Informatics Market Applications, Evolution, Fermentation, Research and Opportunity Assessment 2018-2025
Factors such as reduced cost of sequencing with the use of NGS informatics, increase in initiatives from the government to promote the use of NGS in R&D, enhanced speed & flexibility offered by NGS, and continuous innovation & developments in the technology drive the growth of the global next-generation sequencing informatics market.
Download Sample Copy @ https://www.alliedmarketresearch.com/request-toc-and-sample/2824
However, lack of accuracy, precision, and standardization of the technology and dependence on government initiatives for the development of NGS technology hinder the market growth. Increased incorporation of NGS technology with other research programs and untapped market opportunities in emerging nations are expected to provide growth opportunities for the market.
• GATC Biotech AG
• Biomatters Ltd.
• Genomatix GmbH
• Qiagen N.V.
• Illumina Inc.
• Thermo Fisher Scientific Inc.
• Partek Incorporated.
The global next-generation sequencing informatics market is segmented on the basis of product, technology, application, and region. Based on product, the market is categorized into data analysis & management tool, NGS informatics services, and data interpretation & reporting tools.
The data analysis & management tools segment is sub-segmented into LIMS and computing tools. By technology, the market is classified into whole targeted re-sequencing, genome sequencing, de novo sequencing, exome sequencing, RNA sequencing, chip sequencing, and methyl sequencing.
Applications covered in the study include diagnostics, drug discovery, biomarker discovery, personalized medicine, and agriculture & animals research. Geographically, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
• The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
• Comprehensive analysis of all geographical regions is provided, which helps to determine the prevailing opportunities.
• Key players are profiled and their strategies are analyzed thoroughly, which help to understand competitive outlook of the global market.
• The report offers a quantitative analysis from 2017 to 2023, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
• Exhaustive analysis of the NGS market by product and technology helps in understanding the types of technologies that are currently being used along with the variants that are expected to gain prominence in the future.
Send Enquiry Us @ https://www.alliedmarketresearch.com/purchase-enquiry/2824
Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Next-generation Sequencing Informatics Market Applications, Evolution, Fermentation, Research and Opportunity Assessment 2018-2025 here
News-ID: 1661014 • Views: 209
More Releases from Allied Market Research
North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently
More Releases for NGS
NGS Data Analysis Market to Undertake Strapping Growth During 2026
With continuous developments in cloud computing and data integration solutions, bottlenecks in data handling are being effectively addressed, which includes high throughput sequence data’s sizeable volume analysis. Introduction of NGS solutions coupled with rising clinical diagnosis requirement for personalized treatment of several ailments and genomic research, have created demand for precise and fasts sequencing and algorithms interpretation tools that can analyze data faster. This Fact.MR report analyzes the expansion of
NGS Data Analysis Market to Observe Strong Development by 2026
With continuous developments in cloud computing and data integration solutions, bottlenecks in data handling are being effectively addressed, which includes high throughput sequence data’s sizeable volume analysis. Introduction of NGS solutions coupled with rising clinical diagnosis requirement for personalized treatment of several ailments and genomic research, have created demand for precise and fasts sequencing and algorithms interpretation tools that can analyze data faster. Report overview @ https://www.xploremr.com/report/679/ngs-data-analysis-market This Fact.MR report analyzes
Next-generation Sequencing (NGS) Market Unbeaten over 2025
Next-generation Sequencing (NGS) Market: Snapshot Next Generation Sequencing (NGS) is utilized to execute different applications, for instance, biomarker revelation, oncology thinks about, customized solution, rural and creature research, and others. NGS has streamlined nucleotide investigation and has broadly supplanted customary instruments of genomics, particularly microarray effectively. The interest for NGS has expanded altogether inferable from surge in NGS applications and ascend in mechanical progressions in NGS. What's more, the development in
Next Generation Sequencing (NGS) Data Analysis Market Trepidation In 2025
Next Generation Sequencing (NGS) Data Analysis Market: Snapshot NGS is the term which is used to describe a number of different modern sequencing technologies and is also known as high throughput sequencing. Researchers are allowed to examine the biological systems, deeply due to exceptional throughput, scalability of systems, and speed by the next generation sequencing (NGS). In present times, a greater level of understanding is demanded due to the complexities involved
Global Next Generation Sequencing (NGS) Market Is driven by Increased in adoptio …
The Global Next-Generation Sequencing (NGS) Market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Global Next-Generation Sequencing (NGS) Market for
Next Generation Sequencing (NGS) at a CAGR of 23.59%
The Asia-Pacific NGS market which was worth $ 567.7 million in 2016 is poised to reach $1,636.7 million by 2021 at a CAGR of 23.59%. Asia presents significant opportunities for the investors/venture capitalists as the developed markets are saturated. The presence of noteworthy developments by China and Japan for integration of new technologies and the development of healthcare is majorly driving the Asia Pacific Market. Sample Report Request: https://www.reportsandmarkets.com/sample-request/1214607-12/2016 R&D and